Search research articles
Contact Us
Filters
Showing results (61-70 of 111) with videos related to
Page
of 12
Sort By:
International Journal of Oncology
|
January 19, 2017
VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland
Syed A Hussain, Jawaher Ansari, Robert Huddart, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
October 27, 2025
Evaluating participant experiences and tolerability with MR Linac imaging
Jayde Nartey, Helen A McNair, Katie Biscombe, et al.
Nature Communications
|
January 23, 2015
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Kevin Litchfield, Brenda Summersgill, Shawn Yost, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
Miguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Trials
|
April 5, 2018
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial
Simon Crabb, Sarah J Danson, James W F Catto, et al.
BJUI Compass
|
August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours
Nasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Journal of the National Cancer Institute
|
February 12, 2026
Cardiovascular disease risk among long-term testicular cancer survivors following contemporary cisplatin-based chemotherapy
Sarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Urologic Oncology
|
July 18, 2024
Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxel
Francesca Jackson-Spence, Charlotte Ackerman, Robert Jones, et al.
Nature Communications
|
December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility
Kevin Litchfield, Max Levy, Darshna Dudakia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer
Shaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 111) with videos related to
Sort By:
Page
of 12
International Journal of Oncology
|
January 19, 2017
VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland
Syed A Hussain, Jawaher Ansari, Robert Huddart, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
October 27, 2025
Evaluating participant experiences and tolerability with MR Linac imaging
Jayde Nartey, Helen A McNair, Katie Biscombe, et al.
Nature Communications
|
January 23, 2015
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours
Kevin Litchfield, Brenda Summersgill, Shawn Yost, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2017
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer
Miguel Reis Ferreira, Atia Khan, Karen Thomas, et al.
Trials
|
April 5, 2018
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial
Simon Crabb, Sarah J Danson, James W F Catto, et al.
BJUI Compass
|
August 1, 2025
Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours
Nasreen Abdul Aziz, Kenrick Ng, Constantine Alifrangis, et al.
Journal of the National Cancer Institute
|
February 12, 2026
Cardiovascular disease risk among long-term testicular cancer survivors following contemporary cisplatin-based chemotherapy
Sarah L Kerns, Paul C Dinh, Patrick O Monahan, et al.
Urologic Oncology
|
July 18, 2024
Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxel
Francesca Jackson-Spence, Charlotte Ackerman, Robert Jones, et al.
Nature Communications
|
December 21, 2016
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility
Kevin Litchfield, Max Levy, Darshna Dudakia, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 31, 2016
Prospective Study Delivering Simultaneous Integrated High-dose Tumor Boost (≤70 Gy) With Image Guided Adaptive Radiation Therapy for Radical Treatment of Localized Muscle-Invasive Bladder Cancer
Shaista Hafeez, Karole Warren-Oseni, Helen A McNair, et al.
Page
of 12